![Alan Weichselbaum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Weichselbaum
Director/Board Member at
FINWISE BANCORP
Net worth: 851 900 $ as of 2026-05-30
Profile
Alan Weichselbaum is the founder of The Wexus Group LLC, founded in 2011.
Current jobs include Chairman & Managing Member at Gimmel Partners LP since 2012, Director at Young Israel of Lawrence-Cedarhurst, Director at Tony Power, and Director at FinWise Bancorp since 2022.
Former jobs include CEO, Acting Chief Financial Officer & CAO at Jesup & Lamont, Inc. from 2009 to 2012; Director at Rock Creek Pharmaceuticals, Inc. in 2010; Director at FinWise Bank; Director at FinWise Bancorp from 2015 to 2021; Analyst at Fulcrum Global Partners LLC in 2004; Manager-Financial Planning & Analysis at Philip Morris Capital Corp.; Chief Financial Officer & Treasurer at MIRA Pharmaceuticals, Inc. from 2025 to 2026; and Chief Financial Officer at Telomir Pharmaceuticals, Inc. from 2025 to 2026.
Education includes an undergraduate degree from Queens College in 1986 and an MBA from New York University in 1999.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FINWISE BANCORP 0.43% | 2026-04-20 | 59,242 ( 0.43% ) | 851 900 $ | 2026-05-30 |
| 2025-05-14 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2025-05-14 | 0 ( -.--% ) | - $ | 2026-05-30 |
Alan Weichselbaum active positions
| Companies | Position | Start |
|---|---|---|
| FINWISE BANCORP | Director/Board Member | 2022-09-30 |
Gimmel Partners LP | Chairman | 2005-09-30 |
Young Israel of Lawrence-Cedarhurst | Director/Board Member | - |
Tony Power | Director/Board Member | - |
Former positions of Alan Weichselbaum
| Companies | Position | End |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Director of Finance/CFO | 2026-06-05 |
| TELOMIR PHARMACEUTICALS, INC. | Director of Finance/CFO | 2026-06-05 |
| FINWISE BANCORP | Director/Board Member | 2021-05-06 |
FinWise Bank
 FinWise Bank Regional BanksFinance Provides state chartered commercial banking services | Director/Board Member | 2021-05-06 |
| ROCK CREEK PHARMACEUTICALS, INC. | Director/Board Member | 2010-10-21 |
Training of Alan Weichselbaum
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Rock Creek Pharmaceuticals, Inc.
 Rock Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures a variety of pharmaceutical products | Health Technology |
Fulcrum Global Partners LLC
 Fulcrum Global Partners LLC Investment Banks/BrokersFinance Provides securities research analysis and trade execution services | Finance |
Queens College
 Queens College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philip Morris Capital Corp.
 Philip Morris Capital Corp. Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Finance |
Gimmel Partners LP | |
Young Israel of Lawrence-Cedarhurst | Commercial Services |
Tony Power | |
Jesup & Lamont, Inc.
 Jesup & Lamont, Inc. Investment Banks/BrokersFinance Provides securities brokerage, asset management and market services | Finance |
FinWise Bank
FinWise Bank Regional BanksFinance Provides state chartered commercial banking services | Finance |
FinWise Bancorp
 FinWise Bancorp Regional BanksFinance Operates as a bank holding company whose subsidiary provides banking services | Finance |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
THE WEXUS GROUP LLC
 THE WEXUS GROUP LLC Miscellaneous Commercial ServicesCommercial Services Operates as a a financial firm that provides accounting, vendor management, bookkeeping, marketing strategies and consulting services | Commercial Services |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
- Stock Market
- Insiders
- Alan Weichselbaum
